Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Color Genomics brings in $45mm through Series B round

Executive Summary

Color Genomics Inc. raised $45mm through its Series B round from lead investor General Catalyst (which joins the company's board), singer/songwriter/philanthropist Bono, individual investor and new board member Susan Wagner, 8VC, Khosla Ventures, and Emerson Collective. The company's flagship product is the Color Test, an affordable consumer risk assessment diagnostic that analyzes over 30 genes (including BRCA1 and BRCA2) associated with increased risk for breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancers.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies